Thomas A. Zalewski Named Chief Legal Officer and Chief Compliance Officer of Aquestive Therapeutics

Thomas A. Zalewski was named Chief Legal Officer and Chief Compliance Officer of Aquestive Therapeutics on March 20, 2026, according to an SEC filing.

NameThomas A. Zalewski
RoleChief Legal Officer and Chief Compliance Officer
CompanyAquestive Therapeutics
IndustryPharmaceuticals
LocationWarren, NJ
MoveAppointment
DateMarch 20, 2026
Sourcean SEC filing

Aquestive Therapeutics appointed Thomas A. Zalewski, a partner at Day Pitney who had long advised the company as outside counsel, as Chief Legal Officer and Chief Compliance Officer effective April 2, 2026. He succeeds Lori J. Braender, who remains Corporate Secretary. (Source: an SEC filing.)

Who is the Chief Legal Officer and Chief Compliance Officer of Aquestive Therapeutics?

Thomas A. Zalewski took the Chief Legal Officer and Chief Compliance Officer role at Aquestive Therapeutics in March 2026, as reported by an SEC filing. Legal leadership changes often, so check Aquestive Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

More legal leadership moves at Aquestive Therapeutics

Other general counsel moves in March 2026

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.